- The trend backdrop is active with a 7-week active streak.
- Price is above Fair Value, showing premium demand versus the model.
POCL
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Pondy Oxides And Chemicals Limited · Basic Materials · Specialty Chemicals
Latest close
481.7 INR
-8.6%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is -4.8% below the Trend Line and sits at 35.0% of its 52-week range. The latest completed week returned -8.6%, after a -15.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100.
Setup score
33
out of 100
Latest Close
481.7 INR
7 Aug 2026
1W Return
-8.6%
latest completed week
4W Return
-15.5%
short-term follow-through
12W Return
-22.0%
quarterly tape
Trend Breadth
61.5%
32 of 52 weeks active
Volume Ratio
1.1x
vs 13-week average
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- 6 reversal markers appear in the recent smart-money tape.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-8.6%
Latest completed week; four-week move -15.5%.
Indicator stack
58/28
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
48/100
28 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is -4.8% below the Trend Line and sits at 35.0% of its 52-week range. The latest completed week returned -8.6%, after a -15.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5112-week average 0.52
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.51Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers
No recent accumulation markers. 6 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -15.5% over four weeks, -22.0% over 12 weeks, and 12.5% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year32
Trend breadth61.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.39Latest activity-pressure read.
Pressure change-186.2%Four-week change in activity pressure.
Leadership-5.07Latest relative-leadership reading.
RS change-132.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength46/100Blend of value, momentum, and quality. Underlying universe rank 55; rank 1 is best.
Value39/100Relative valuation strength. Underlying universe rank 62; rank 1 is best.
Quality38/100Profitability and accounting quality. Underlying universe rank 63; rank 1 is best.
Momentum78/100Medium-term price momentum. Underlying universe rank 23; rank 1 is best.
Growth97/100Revenue and earnings growth. Underlying universe rank 4; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework62/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 27.9x Price divided by trailing earnings.
- Price / sales
- 1.2x Market value relative to trailing revenue.
- EV / EBITDA
- 17.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -2.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 11.5% Gross profit retained from each unit of revenue.
- Operating margin
- 6.3% Operating profit retained from revenue.
- Free-cash-flow margin
- -3.2% Free cash flow generated from revenue.
- Return on invested capital
- 15.0% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 43.8% Latest one-year revenue growth.
- EPS growth
- 109.4% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.3% Cash dividends relative to market value.
- Buyback yield
- -1.2% Net share repurchases relative to market value.
- Shareholder yield
- -0.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment48/100
Weighted news tone is neutral across 28 relevant articles.
3 positive · 22 neutral · 3 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-25.6%Distance below the 52-week high.
13-week volatility5.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+14.1%Week of 1 May.
Worst week-13.3%Week of 29 May.
Latest week-8.6%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains7
Flat weeks0
Modest losses10
Sharp losses4
Recent vol5.9%13-week weekly-return volatility.
Base vol6.3%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -4.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank98 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape38/100
Trend, activity pressure, participation, and risk combine to a 38/100 tape read.
Indicator analysis59/100Latest 12-week confirmation: trend 7/12, activity pressure 10/12, relative leadership 11/12.
Activity pressure 0.51; 6 reversal markers Factors48/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 84; Small Cap Core rank 65 SVQF62/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 592.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment48/100Weighted news tone is neutral across 28 relevant articles.
Neogen Chemicals Publishes Q1 FY27 Earnings Presentation Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 481.7 INR | -8.6% | 506.0 INR | 325.9 INR | -0.39 | -5.07 | 5.0M | On |
| 31 Jul 2026 | 527.0 INR | 0.2% | 508.6 INR | 323.4 INR | -0.06 | 4.85 | 1.9M | On |
| 24 Jul 2026 | 526.2 INR | -3.8% | 511.6 INR | 320.6 INR | 0.25 | 7.58 | 2.4M | On |
| 17 Jul 2026 | 547.2 INR | -4.0% | 513.4 INR | 317.8 INR | 0.36 | 9.82 | 2.0M | On |
| 10 Jul 2026 | 570.0 INR | 0.3% | 512.5 INR | 314.8 INR | 0.45 | 15.71 | 5.2M | On |
| 3 Jul 2026 | 568.2 INR | 7.8% | 510.9 INR | 311.6 INR | 0.36 | 15.92 | 7.8M | On |
| 26 Jun 2026 | 526.9 INR | -1.9% | 509.3 INR | 308.5 INR | 0.30 | 9.39 | 1.8M | On |
| 19 Jun 2026 | 537.2 INR | 6.3% | 508.9 INR | 305.6 INR | 0.40 | 12.66 | 2.7M | Off |
| 12 Jun 2026 | 505.4 INR | -1.8% | 508.9 INR | 302.7 INR | 0.54 | 8.93 | 2.5M | Off |
| 5 Jun 2026 | 514.6 INR | 0.1% | 510.9 INR | 300.0 INR | 0.72 | 13.14 | 4.0M | Off |
| 29 May 2026 | 514.1 INR | -13.3% | 511.0 INR | 297.2 INR | 0.82 | 13.28 | 9.1M | Off |
| 22 May 2026 | 592.9 INR | -4.1% | 512.2 INR | 294.4 INR | 0.84 | 30.97 | 5.3M | Off |
| 15 May 2026 | 617.9 INR | 7.9% | 510.7 INR | 291.0 INR | 0.53 | 38.74 | 8.9M | Off |
| 8 May 2026 | 572.6 INR | 3.9% | 508.4 INR | 287.5 INR | 0.23 | 27.38 | 3.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.